Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

This $117 billion Australian success story asked the US government to give it a break on tariffs, but is now waiting to see ...

Merck is looking to strengthen its respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.

Verona Pharma VRNA has signed a definitive agreement with pharma bigwig Merck MRK. Per the terms, the pharma giant will ...

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of ...

JNJ's growth outlook, rising estimates, and strength in Innovative Medicine give it an edge over Pfizer in 2025.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Glenmark Pharma's shares rose by 10% after the company's subsidiary secured a global licensing agreement for its investigational asset, ISB 2001, with New York-based AbbVie.

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Pharmaceutical giant Merck & Co. (MRK) is buying British lung therapy firm Verona Pharma (VRNA) for $10 billion U.S. In a written statement, Merck said the deal will strengthen its respiratory ...